The evolution of antipsychotic medication: A long-acting, injectable formulation of a second-generation antipsychotic

Simple item page
dc.contributor.authorOosthuizen P.
dc.date.accessioned2011-05-15T15:57:46Z
dc.date.available2011-05-15T15:57:46Z
dc.date.issued2006
dc.description.abstract[No abstract available]
dc.description.versionEditorial
dc.identifier.citationSouth African Journal of Psychiatry
dc.identifier.citation12
dc.identifier.citation2
dc.identifier.issn16089685
dc.identifier.urihttp://hdl.handle.net/10019.1/10586
dc.subjectfluphenazine
dc.subjectlong acting drug
dc.subjectneuroleptic agent
dc.subjectrisperidone
dc.subjectclinical trial
dc.subjectdelusion
dc.subjectdrug efficacy
dc.subjectdrug formulation
dc.subjectdrug safety
dc.subjectdrug tolerability
dc.subjecteditorial
dc.subjectfunctional status
dc.subjecthealth care availability
dc.subjecthuman
dc.subjectinjection
dc.subjectpatient compliance
dc.subjectpsychoeducation
dc.subjectquality of life
dc.subjectschizophrenia
dc.titleThe evolution of antipsychotic medication: A long-acting, injectable formulation of a second-generation antipsychotic
dc.typeEditorial
Files
Collections
Stellenbosch University - Scopus Publications